CClinicalTrials.gg
WithdrawnNCT03289104ClosureUpdated Dec 17, 2018

Improving Sternal Healing After Cardiac Surgery: Sternal Wire vs ZIPFIX

An interventional study of Steel Wires and ZipFix Sternal Closure System in Sternal Injury, Cardiac Surgery and Heart Diseases, sponsored by Ottawa Heart Institute Research Corporation. Withdrawn at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-12-17.

Sponsored by Ottawa Heart Institute Research Corporation · Not applicable, Interventional, and Treatment

Why this study was withdrawn
Study terminated due to inadequate funding.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The objective of this study is to determine whether sternal reconstruction using the ZIPFIX system compared to standard wire cerclage could improve bone healing, patient function, and decreased postoperative pain.

Read the detailed description

Despite a longer time for bone healing and functional recovery, median sternotomy is still the most common approach in cardiac surgery. Sternal closure has traditionally been wire cerclage using stainless steel wires, however, new sternal fixation devices have been developed to improve sternal union. Rigid sternal fixation, although very costly, has demonstrated to be superior to standard wire cerclage both in clinical and biomechanical studies. Although improved sternal healing was observed with rigid plate fixation in a randomized controlled trial in high risk patients, the wound complication rate with plate fixation was almost double that of wire cerclage albeit not statistically significant.

A novel sternal closure system denoted the sternal ZIPFIX system (DePuySynthes, Companies of Johnson and Johnson, West Over, PA, US) is biocompatible Poly-Ether-Ether-Ketone implant that was developed for fast and reliable sternal fixation following median sternotomy. First published case series utilized the sternal ZIPFIX System demonstrating effective sternal stability at 30 days. Another study has demonstrated no significant difference in the incidence of sternal wound infection following the ZIPFIX system compared to standard wire cerclage while Stelly et al., 2015 demonstrated reduced risk of deep sternal wound infection for patients using ZIPFIX. The ZIPFIX system demonstrates a higher resistance of fatigue failure and has a larger implant-to-bone contact area compared to stainless steel wires thereby reducing the risk of bone cut through. Placement of the cable ties are done similar to wire cerclage thereby not affecting time for sternal closure and training.

The objective of this study is to determine whether sternal reconstruction using the ZIPFIX system compared to standard wire cerclage would improve bone healing, patient function, and decrease postoperative pain.

02

Conditions studied

  • Sternal Injury
  • Cardiac Surgery
  • Heart Diseases

Browse trials for

03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient age ≥ 18 years
  • Scheduled cardiac surgery including coronary artery bypass grafting, aortic valve replacement, mitral valve replacement/repair, or ascending aorta replacement.
  • Patient undergoing elective or urgent surgery
  • Ability to understand study procedures and to comply with them for the entire length of the study.

Exclusion criteria

Exclusion Criteria:

  • Patients undergoing emergent cardiac surgery
  • Severe congestive heart failure (NYHA class III or IV) at enrollment
  • Prior cardiac surgery
  • Patients undergoing ventricular assist device insertion or heart transplantation
  • Patients with a known metal allergy or allergy to ZIPFIX implant
  • Patients who refuses consent
  • Patients who are unable to follow post-operative instructions
  • Prior history of significant bleeding that might be expected to recur with cardiac surgery
  • Dementia with a mini mental status examination (MMSE) score of \< 20
  • Extra cardiac illness that is expected to limit survival to less than 5 years
  • Suspected pregnancy. A pregnancy test (urine or serum) will be administered to all women not clearly menopausal
  • Concurrent enrollment in another clinical trial
  • Geographic inaccessibility for follow-up visits required by the protocol
  • Prisoners or institutionalized individuals
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
0 participants (actual)

Study arms

  • Active comparator
    Steel Wires

    In this arm, patients will have their sternum closed with steel wires.

    Device: Steel Wires

  • Experimental
    ZipFix Sternal Closure System (Plastic Cables)

    In this arm, patients will have their sternum closed with the ZipFix system.

    Device: ZipFix Sternal Closure System

Interventions

  • DeviceSteel Wires

    Control: Steel wires (device) are selected for sternal closure after surgery. Currently, most patients who have a sternotomy during cardiac surgery have their sternum closed with steel wires.

  • DeviceZipFix Sternal Closure System

    Treatment: ZipFix system (device) are selected for sternal closure after surgery. These plastic cables can also be used to close the sternum during bypass surgery.

05

What researchers measure

Primary outcomes

  1. Sternal bone healing

    Assessment of how the sternum is healing, assessed via a CT scan and classified using a 6-point scale.

    Time frame: 3 months after surgery

Secondary outcomes

  1. Post-operative pain

    A patient's subjective assessment of their pain after surgery.

    Time frame: Within 1 week of surgery

  2. Use of narcotics

    A patient's use of narcotic pain medication. To assess this measure, the proportion of patients in each group using narcotic pain medication will be compared.

    Time frame: In the first 6 months after surgery

  3. Sternal instability

    Clinical assessment of patient's sternum stability after surgery

    Time frame: In the first 6 months after surgery

  4. Sternal wound infection

    The presence of sternal wound infection after surgery, confirmed by wound cultures

    Time frame: In the first 6 months after surgery

  5. Cost

    An approximation of the comparative cost of the ZipFix system versus sternal wires, which will be approximated by comparing the duration of hospital stay between groups; the use of narcotic pain medication between groups; and the rate of sternal wound infection between groups.

    Time frame: In the first 6 months after surgery.

06

Study locations

1 site
  • Division of Cardiac Surgery
    Ottawa, Ontario K1Y4W7, Canada
07

References and documents

Publications

  • Karamlou T, Jacobs ML, Pasquali S, He X, Hill K, O'Brien S, McMullan DM, Jacobs JP. Surgeon and center volume influence on outcomes after arterial switch operation: analysis of the STS Congenital Heart Surgery Database. Ann Thorac Surg. 2014 Sep;98(3):904-11. doi: 10.1016/j.athoracsur.2014.04.093. Epub 2014 Jul 25. PubMed 25069686 ↗
  • Kozower BD, Sheng S, O'Brien SM, Liptay MJ, Lau CL, Jones DR, Shahian DM, Wright CD. STS database risk models: predictors of mortality and major morbidity for lung cancer resection. Ann Thorac Surg. 2010 Sep;90(3):875-81; discussion 881-3. doi: 10.1016/j.athoracsur.2010.03.115. PubMed 20732512 ↗
  • Raman J, Song DH, Bolotin G, Jeevanandam V. Sternal closure with titanium plate fixation--a paradigm shift in preventing mediastinitis. Interact Cardiovasc Thorac Surg. 2006 Aug;5(4):336-9. doi: 10.1510/icvts.2005.121863. Epub 2006 Apr 25. PubMed 17670585 ↗
  • Pai S, Gunja NJ, Dupak EL, McMahon NL, Roth TP, Lalikos JF, Dunn RM, Francalancia N, Pins GD, Billiar KL. In vitro comparison of wire and plate fixation for midline sternotomies. Ann Thorac Surg. 2005 Sep;80(3):962-8. doi: 10.1016/j.athoracsur.2005.03.089. PubMed 16122464 ↗
  • Losanoff JE, Basson MD, Gruber SA, Huff H, Hsieh FH. Single wire versus double wire loops for median sternotomy closure: experimental biomechanical study using a human cadaveric model. Ann Thorac Surg. 2007 Oct;84(4):1288-93. doi: 10.1016/j.athoracsur.2007.05.023. PubMed 17888985 ↗
  • Losanoff JE, Collier AD, Wagner-Mann CC, Richman BW, Huff H, Hsieh Fh, Diaz-Arias A, Jones JW. Biomechanical comparison of median sternotomy closures. Ann Thorac Surg. 2004 Jan;77(1):203-9. doi: 10.1016/s0003-4975(03)01468-1. PubMed 14726062 ↗
  • Song DH, Lohman RF, Renucci JD, Jeevanandam V, Raman J. Primary sternal plating in high-risk patients prevents mediastinitis. Eur J Cardiothorac Surg. 2004 Aug;26(2):367-72. doi: 10.1016/j.ejcts.2004.04.038. PubMed 15296898 ↗
  • Grapow MT, Melly LF, Eckstein FS, Reuthebuch OT. A new cable-tie based sternal closure system: description of the device, technique of implantation and first clinical evaluation. J Cardiothorac Surg. 2012 Jun 25;7:59. doi: 10.1186/1749-8090-7-59. PubMed 22731778 ↗
  • Melly L, Gahl B, Meinke R, Rueter F, Matt P, Reuthebuch O, Eckstein FS, Grapow MT. A new cable-tie-based sternal closure device: infectious considerations. Interact Cardiovasc Thorac Surg. 2013 Aug;17(2):219-23; discussion 223-4. doi: 10.1093/icvts/ivt183. Epub 2013 Apr 26. PubMed 23624983 ↗
  • Stelly MM, Rodning CB, Stelly TC. Reduction in deep sternal wound infection with use of a peristernal cable-tie closure system: a retrospective case series. J Cardiothorac Surg. 2015 Nov 14;10:166. doi: 10.1186/s13019-015-0378-7. PubMed 26577944 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03289104
Lead sponsor
Ottawa Heart Institute Research Corporation
Responsible party
Marc Ruel MD MPH FRCSC (Chief Cardiac Surgeon, Ottawa Heart Institute Research Corporation) — Principal investigator
First posted
Sep 20, 2017
Start date
Sep 2018 (estimated)
Primary completion
Sep 2020 (estimated)
Completion
Sep 2020 (estimated)
Last update
Dec 17, 2018

Study contacts

Marc Ruel, MD, MPH
principal investigator · Ottawa Heart Institute Research Corporation

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion